» Articles » PMID: 28692701

Molecular Features of Influenza A (H1N1)pdm09 Prevalent in Mexico During Winter Seasons 2012-2014

Abstract

Since the emergence of the pandemic H1N1pdm09 virus in Mexico and California, biannual increases in the number of cases have been detected in Mexico. As observed in previous seasons, pandemic A/H1N1 09 virus was detected in severe cases during the 2011-2012 winter season and finally, during the 2013-2014 winter season it became the most prevalent influenza virus. Molecular and phylogenetic analyses of the whole viral genome are necessary to determine the antigenic and pathogenic characteristics of influenza viruses that cause severe outcomes of the disease. In this paper, we analyzed the evolution, antigenic and genetic drift of Mexican isolates from 2009, at the beginning of the pandemic, to 2014. We found a clear variation of the virus in Mexico from the 2011-2014 season due to different markers and in accordance with previous reports. In this study, we identified 13 novel substitutions with important biological effects, including virulence, T cell epitope presented by MHC and host specificity shift and some others substitutions might have more than one biological function. The systematic monitoring of mutations on whole genome of influenza A pH1N1 (2009) virus circulating at INER in Mexico City might provide valuable information to predict the emergence of new pathogenic influenza virus.

Citing Articles

Transmission of infectious viruses in the natural setting at human-animal interface.

Nandi J, Rathore S, Mathur B Curr Res Virol Sci. 2021; 2:100008.

PMID: 34250513 PMC: 8256691. DOI: 10.1016/j.crviro.2021.100008.


Phylodynamics of Influenza A/H1N1pdm09 in India Reveals Circulation Patterns and Increased Selection for Clade 6b Residues and Other High Mortality Mutants.

Adam D, Scotch M, MacIntyre C Viruses. 2019; 11(9).

PMID: 31462006 PMC: 6783925. DOI: 10.3390/v11090791.


Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development.

Sankar S, Ramamurthy M, Suganya S, Nandagopal B, Sridharan G Bioinformation. 2018; 14(5):183-189.

PMID: 30108413 PMC: 6077822. DOI: 10.6026/97320630014183.


Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.

Canche-Pech J, Conde-Ferraez L, Puerto-Solis M, Gonzalez-Losa R, Granja-Perez P, Villanueva-Jorge S PLoS One. 2017; 12(12):e0189363.

PMID: 29220381 PMC: 5722308. DOI: 10.1371/journal.pone.0189363.

References
1.
Peiris J, Poon L, Guan Y . Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009; 45(3):169-73. PMC: 4894826. DOI: 10.1016/j.jcv.2009.06.006. View

2.
Wang W, Suguitan Jr A, Zengel J, Chen Z, Jin H . Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage. Vaccine. 2011; 30(5):872-8. DOI: 10.1016/j.vaccine.2011.11.101. View

3.
Gulati U, Hwang C, Venkatramani L, Gulati S, Stray S, Lee J . Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol. 2002; 76(23):12274-80. PMC: 136895. DOI: 10.1128/jvi.76.23.12274-12280.2002. View

4.
. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004; 303(5664):1666-9. DOI: 10.1126/science.1092002. View

5.
Perez-Padilla R, Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E . Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009; 361(7):680-9. DOI: 10.1056/NEJMoa0904252. View